Peptide Reports

AHK-Cu

Community Protocol

AHK-Cu

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Educational and calculation-reference material only. Community reports are uncontrolled anecdotes and do not replace professional medical guidance, product labeling, or individualized clinical monitoring.

Scope

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Available strengths: 50 MG and 100 MG

Preparation Examples

These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.

SetupDiluentConcentrationUnit conversion
50 MG vial – 2 mL exampleAdd 2 mL bacteriostatic water25 mg/mLEach U-100 unit = 250 mcg
100 MG vial – 2 mL exampleAdd 2 mL bacteriostatic water50 mg/mLEach U-100 unit = 500 mcg

Syringe Conversion

Reported amount50 MG setup100 MG setup
500 mcg2 units1 units
1 mg4 units2 units
2 mg8 units4 units
3 mg12 units6 units

Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.

Community-Reported Patterns

Recurring reportFrequency seenContext in reports
0.5-1 mgDailyLower-start reports
1-2 mgDaily or near-dailyHair and skin discussions
2-3 mgDaily in some reportsHigher experimental use

Observations

  • Community discussions most often centered on hair appearance, skin quality and copper-peptide research.
  • The amount, frequency, route and cycle length varied substantially between reports.
  • Reported outcomes were commonly confounded by diet, training, other products or existing treatment.

Caveats

  • Copper-peptide exposure and systemic copper balance require caution; online reports do not replace clinical monitoring.
  • Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.

Sources

  1. Community search: AHK-Cu
  2. PubMed literature search: AHK-Cu